drugset
drugset / Trial / NCT00002188

A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

NCT00002188 ↗

Phase 2 Completed 27 enrolled Anderson Clinical Research Ligand Pharmaceuticals · collab
Treatment

Summary

The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject alitretinoin Other / unclassified — Oral

Indications

HIV infectious disease Kaposi's sarcoma